Interestingly, in the last decade, studies have revealed an association between subnormal insulin-like growth factor-1 (IGF-1) levels and various MetS components, including obesity, dyslipidaemia, IR and hyperglycaemia [77,78]. Here, IGF1 is linked to obesity disorder.